These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16784910

  • 1. Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction?
    Tu K, Gunraj N, Mamdani M.
    Am J Cardiol; 2006 Jul 01; 98(1):6-9. PubMed ID: 16784910
    [Abstract] [Full Text] [Related]

  • 2. Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure.
    Tu K, Mamdani M, Kopp A, Lee D.
    Am J Cardiol; 2005 Jan 15; 95(2):283-6. PubMed ID: 15642572
    [Abstract] [Full Text] [Related]

  • 3. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K, Fukami K, Hiramori K, Hosoda S, Kishida H, Kato K, Fujita T, Tsutani K, Sakuma A, Japanese Acute Myocardial Infarction Prospective study group.
    Am Heart J; 2004 Aug 15; 148(2):e8. PubMed ID: 15309011
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J, Investigadores del PRIAMHO II.
    Rev Esp Cardiol; 2006 Apr 15; 59(4):313-20. PubMed ID: 16709383
    [Abstract] [Full Text] [Related]

  • 6. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG, Athyros VG, Papageorgiou AA, Skeberis VM, Basayiannis EC, Boudoulas H.
    Coron Artery Dis; 1997 Apr 15; 8(8-9):517-24. PubMed ID: 9431480
    [Abstract] [Full Text] [Related]

  • 7. Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction.
    Milonas C, Jernberg T, Lindbäck J, Agewall S, Wallentin L, Stenestrand U, RIKS-HIA Group.
    Am J Cardiol; 2010 May 01; 105(9):1229-34. PubMed ID: 20403471
    [Abstract] [Full Text] [Related]

  • 8. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
    Bourgault C, Elstein E, Le Lorier J, Suissa S.
    CMAJ; 1999 Aug 10; 161(3):255-60. PubMed ID: 10463046
    [Abstract] [Full Text] [Related]

  • 9. Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction.
    Hansen ML, Gislason GH, Køber L, Schramm TK, Folke F, Buch P, Abildstrom SZ, Madsen M, Rasmussen S, Torp-Pedersen C.
    Br J Clin Pharmacol; 2008 Feb 10; 65(2):217-23. PubMed ID: 17711535
    [Abstract] [Full Text] [Related]

  • 10. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up.
    Berton G, Cordiano R, Cucchini F, Cavuto F, Pellegrinet M, Palatini P.
    Int J Clin Pract; 2009 May 10; 63(5):712-21. PubMed ID: 19392921
    [Abstract] [Full Text] [Related]

  • 11. Association between time of statin initiation after hospital discharge from acute myocardial infarction and risk of recurrence and mortality in patients > or =65 years of age.
    Zhou Z, Rahme E, Pilote L.
    Am J Cardiol; 2006 Jan 15; 97(2):155-9. PubMed ID: 16442354
    [Abstract] [Full Text] [Related]

  • 12. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
    Gislason GH, Rasmussen JN, Abildstrøm SZ, Gadsbøll N, Buch P, Friberg J, Rasmussen S, Køber L, Stender S, Madsen M, Torp-Pedersen C.
    Eur Heart J; 2006 May 15; 27(10):1153-8. PubMed ID: 16399775
    [Abstract] [Full Text] [Related]

  • 13. Quality of care of international and Canadian medical graduates in acute myocardial infarction.
    Ko DT, Austin PC, Chan BT, Tu JV.
    Arch Intern Med; 2005 Feb 28; 165(4):458-63. PubMed ID: 15738378
    [Abstract] [Full Text] [Related]

  • 14. The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
    Kvan E, Reikvam A, INPHARM Study Investigators.
    Eur J Clin Pharmacol; 2004 May 28; 60(3):205-10. PubMed ID: 15034703
    [Abstract] [Full Text] [Related]

  • 15. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
    Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2004 Jan 28; 20(1):61-7. PubMed ID: 14968144
    [Abstract] [Full Text] [Related]

  • 16. Impact of ramipril on the circadian periodicity of acute myocardial infarction.
    Dagenais GR, Pogue J, Teo KK, Lonn EM, Yusuf S, HOPE Study Investigators.
    Am J Cardiol; 2006 Sep 15; 98(6):758-60. PubMed ID: 16950179
    [Abstract] [Full Text] [Related]

  • 17. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R, Papa K, Bernocchi P, Gimbatti OJ, Golcea SS, Bettini A, Ceconi C.
    Ital Heart J; 2005 Nov 15; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [Abstract] [Full Text] [Related]

  • 18. Impact of ACE inhibitors on mortality and morbidity in patients with AMI: Does tissue selectivity matter?
    Kalsekar I, Koehler J, Mulvaney J.
    Value Health; 2011 Jan 15; 14(1):184-91. PubMed ID: 21211501
    [Abstract] [Full Text] [Related]

  • 19. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
    Rasmussen S, Abildstrom SZ, Rasmussen JN, Gislason GH, Schramm TK, Folke F, Køber L, Torp-Pedersen C, Madsen M.
    Med Care; 2008 Jan 15; 46(1):70-7. PubMed ID: 18162858
    [Abstract] [Full Text] [Related]

  • 20. [How should ACE inhibitors be used in myocardial infarction?].
    Reikvam A, Madsen S.
    Tidsskr Nor Laegeforen; 2000 Nov 20; 120(28):3413-7. PubMed ID: 11187196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.